Pneumocystis pneumonia is a serious fungal infection affecting individuals with weakened immune systems, particularly those with HIV/AIDS or undergoing chemotherapy. It causes inflammation and fluid buildup in the lungs, leading to symptoms like shortness of breath, fever, and cough.

Bactrim

Trimethoprim

400/80|800/160mg

Cleocin

Clindamycin

150|300mg

Pneumocystis Jirovecii Pneumonia (PCP) FAQ


What causes Pneumocystis pneumonia?

It's caused by the fungus Pneumocystis jirovecii, which affects people with compromised immune systems.

Who is at risk of developing PCP?

Individuals with HIV/AIDS, cancer patients undergoing chemotherapy, and organ transplant recipients.

What are common symptoms of PCP?

Shortness of breath, fever, cough, chest pain, and rapid breathing.

How is PCP diagnosed?

Through analysis of respiratory secretions, imaging tests (e.g., chest X-ray, CT scan), and blood tests.

Is PCP contagious?

No, it's not directly contagious from person to person.

What is the primary treatment for PCP?

Trimethoprim-sulfamethoxazole (TMP-SMX) is the first-line treatment.

How long does PCP treatment typically last?

Usually 14-21 days, depending on the severity and individual response.

Can PCP be prevented?

Yes, through prophylactic medication for high-risk individuals.

What are common prophylactic medications for PCP?

TMP-SMX, dapsone, or atovaquone for high-risk patients.

How does PCP affect the lungs?

It causes inflammation and fluid accumulation, impairing lung function.

Can PCP be fatal if untreated?

Yes, especially in severely immunocompromised individuals.

Are there alternative treatments for TMP-SMX intolerance?

Yes, alternatives include clindamycin, dapsone, or atovaquone.

What is the recovery time for PCP?

Recovery varies; most see improvement within 1-2 weeks of treatment.

How is PCP managed in Malaysia?

Through antifungal medications, supportive care, and addressing the underlying immune issue.

Can I get PCP after recovering from it?

Yes, recurrence is possible without ongoing prophylaxis in high-risk individuals.

Releated topics